Endosight is a groundbreaking brand in the field of interventional oncology. They specialize in developing innovative products and services that augment the effectiveness of ablation procedures. Their flagship product is the first navigation system based on Augmented-Reality (AR) technology.

Using a 3D reconstruction of CT images, Endosight's system allows physicians to visualize and precisely target tumors within a patient's body, all in augmented reality. This cutting-edge technology provides real-time visualization of important structures such as big vessels and bones, facilitating intuitive and accurate treatment planning during interventions. Endosight is dedicated to improving the precision and efficiency of interventional oncology procedures, ultimately benefitting patients by ensuring optimal outcomes.

For further information about their products and services, including how to get in touch, visit their website. Endosight's commitment to advancing interventional oncology establishes them as a leader in revolutionizing cancer treatment